Cardiac Center News

In light the ongoing challenges, it is so important to celebrate our colleagues. This edition, as I think of our CHOP Alumni Motto: Keep … Tradition, Keep … in Mind and Keep … in Touch!

Over the past 50 years, medical and technological advances in pediatric cardiology and cardiothoracic surgery have resulted in a large decline in mortality among children with congenital and acquired heart disease. 

Ethan is 16-year-old male who presents to the Lipid Heart Clinic for further evaluation of his dyslipidemia. Past history reveals an otherwise healthy adolescent who experienced a 50-pound weight gain over the past year without height increase.

Adults with congenital heart disease (CHD) now outnumber children with CHD because of excellent surgical and medical care in childhood. Lifelong cardiology follow-up is recommended for almost all people with congenital heart disease. Interventions done in childhood are typically palliative and not curative.

In late April 2020, there were reports from the United Kingdom of otherwise healthy children presenting with a severe inflammatory disease similar to Kawasaki disease in the setting of COVID-19. There have been several case definitions since then, and in May 2020, the U.S. Centers for Disease Control and Prevention (CDC) defined this condition as the multi-system inflammatory syndrome in children (MIS-C), which was the diagnosis for our patient.

The AmSECT Pillar Award is a designation for individual perfusion departments which demonstrate excellence as displayed in a number of key areas.

CHOP researchers participated in clinical trial that led to approval of Harmony™ Transcatheter Pulmonary Valve (TPV), which allows for valve replacement without open-heart surgery.

Early recognition, treatment and management of CDH-related pulmonary hypertension is critical. Our team takes an early and aggressive approach to treatment, and our protocols have been extremely successful.

In honor of Women’s History Month, the Cardiac Center at Children's Hospital of Philadelphia (CHOP) invites you to meet a few members of our talented team.

Four-year-old Zach Reesey received a second chance at life through a heart transplant.